Paper39826432
Prolonged immune response to tick-borne Ehrlichia chaffeensis infection using a genetically modified live vaccine.
Madesh S and 12 others. Vaccine, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Prolonged immune response to tick-borne Ehrlichia chaffeensis infection using a genetically modified live vaccine. Papers, record 39826432. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39826432
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prolonged immune response to tick-borne Ehrlichia chaffeensis infection using a genetically modified live vaccine.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ehrlichiosis | Major topic |
| Ehrlichia chaffeensis | Major topic |
| Bacterial Vaccines | Major topic |
| Dog Diseases | Major topic |
| Tick-Borne Diseases | Major topic |
| Animals | |
| Dogs | |
| Vaccines, Attenuated | |
| Antibodies, Bacterial | |
| Immunoglobulin G | |
| Female | |
| CD4-Positive T-Lymphocytes | |
| Ticks | |
| Vaccination |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI070908 | NIAID NIH HHS | United States | R01AI070908 | PubMed and NIH | NIH RePORTER |
| R01 AI152418 | NIAID NIH HHS | United States | R01AI152418 | PubMed and NIH | NIH RePORTER |
| R56 AI070908 | NIAID NIH HHS | United States | R01AI070908 | PubMed and NIH | NIH RePORTER |
| R56AI070908 | NIH | NIH RePORTER |
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8370734 | Impact of persistent Anaplasma marginale rickettsemia on tick infection and transmission. | J Clin Microbiol | 1993 | https://conductscience.org/library/papers/8370734 | PubMed |
| 2 | 24330198 | Severe life-threatening Ehrlichia chaffeensis infections transmitted through solid organ transplantation. | Transpl Infect Dis | 2014 | https://conductscience.org/library/papers/24330198 | PubMed |
| 3 | 10738026 | Transmission of tick-borne agents of disease by blood transfusion: a review of known and potential risks in the United States. | Transfusion | 2000 | https://conductscience.org/library/papers/10738026 | PubMed |
| 4 | 31732168 | Liver Is a Generative Site for the B Cell Response to Ehrlichia muris. | Immunity | 2019 | https://conductscience.org/library/papers/31732168 | PubMed |
| 5 | 29670161 | Impact of Three Different Mutations in Ehrlichia chaffeensis in Altering the Global Gene Expression Patterns. | Sci Rep | 2018 | https://conductscience.org/library/papers/29670161 | PubMed |
| 6 | 17060466 | Differential clearance and immune responses to tick cell-derived versus macrophage culture-derived Ehrlichia chaffeensis in mice. | Infect Immun | 2007 | https://conductscience.org/library/papers/17060466 | PubMed |
| 7 | 23459099 | Targeted and random mutagenesis of Ehrlichia chaffeensis for the identification of genes required for in vivo infection. | PLoS Pathog | 2013 | https://conductscience.org/library/papers/23459099 | PubMed |
| 8 | 26841025 | Vaccination with an Attenuated Mutant of Ehrlichia chaffeensis Induces Pathogen-Specific CD4+ T Cell Immunity and Protection from Tick-Transmitted Wild-Type Challenge in the Canine Host. | PLoS One | 2016 | https://conductscience.org/library/papers/26841025 | PubMed |
| 9 | 38880695 | Genetically modified live vaccine offers protective immunity against wild-type Anaplasma marginale tick-transmission challenge. | Vaccine | 2024 | https://conductscience.org/library/papers/38880695 | PubMed |
| 10 | 1181449 | Laboratory rearing procedures and equipment for multi-host ticks (Acarina: Ixodidae). | J Med Entomol | 1975 | https://conductscience.org/library/papers/1181449 | PubMed |
| 11 | 21915290 | Ehrlichia chaffeensis transcriptome in mammalian and arthropod hosts reveals differential gene expression and post transcriptional regulation. | PLoS One | 2011 | https://conductscience.org/library/papers/21915290 | PubMed |
| 12 | 26186429 | Mutations in Ehrlichia chaffeensis Causing Polar Effects in Gene Expression and Differential Host Specificities. | PLoS One | 2015 | https://conductscience.org/library/papers/26186429 | PubMed |
| 13 | 29570776 | The roles of resident, central and effector memory CD4 T-cells in protective immunity following infection or vaccination. | Immunology | 2018 | https://conductscience.org/library/papers/29570776 | PubMed |
| 14 | 18770537 | Laboratory maintenance of Ehrlichia chaffeensis and Ehrlichia canis and recovery of organisms for molecular biology and proteomics studies. | Curr Protoc Microbiol | 2008 | https://conductscience.org/library/papers/18770537 | PubMed |
| 15 | 27092553 | NK Cell-Mediated Regulation of Protective Memory Responses against Intracellular Ehrlichial Pathogens. | PLoS One | 2016 | https://conductscience.org/library/papers/27092553 | PubMed |
| 16 | 12525424 | Ehrlichia chaffeensis: a prototypical emerging pathogen. | Clin Microbiol Rev | 2003 | https://conductscience.org/library/papers/12525424 | PubMed |
| 17 | 19819631 | Natural history of Ehrlichia chaffeensis: vertebrate hosts and tick vectors from the United States and evidence for endemic transmission in other countries. | Vet Parasitol | 2010 | https://conductscience.org/library/papers/19819631 | PubMed |
| 18 | 29051764 | Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination. | Front Immunol | 2017 | https://conductscience.org/library/papers/29051764 | PubMed |
| 19 | 8225751 | Estimation of vaccine effectiveness using the screening method. | Int J Epidemiol | 1993 | https://conductscience.org/library/papers/8225751 | PubMed |
| 20 | 32723916 | An Entry-Triggering Protein of Ehrlichia Is a New Vaccine Candidate against Tick-Borne Human Monocytic Ehrlichiosis. | mBio | 2020 | https://conductscience.org/library/papers/32723916 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42795548 | Global Trends in Vaccine Research on Ehrlichia and Anaplasma: A Bibliometric Review. | Microorganisms | 2026 | https://conductscience.org/library/papers/42795548 | PubMed |
| 41844092 | Targeted mutagenesis in Ehrlichia canis deleting the phage head-to-tail connector protein gene and its assessment as a vaccine candidate preventing canine ehrlichiosis. | Vaccine | 2026 | https://conductscience.org/library/papers/41844092 | PubMed |
| 41668111 | The 'teabag method': tick feeding protocol and the effects of tick feeding on hematological parameters in the canine host. | Parasit Vectors | 2026 | https://conductscience.org/library/papers/41668111 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39826432
GET https://conductscience.org/api/papers/v1/39826432/references?page=2